HCA Healthcare Inc. (NYSE: HCA) was reiterated as Outperform and the price target was raised to $155 from $145 at BMO Capital Markets. Morgan Stanley maintained it as Underweight but raised the price target to $124 from $115. HCA was down eight cents at $134.03 on Tuesday, in a 52-week range of $71.18 to $138.18.
Humana Inc. (NYSE: HUM) was maintained as Overweight and the price target was raised to $400 from $365 (versus a $333.09 close) at Morgan Stanley.
Mondelez International Inc. (NASDAQ: MDLZ) was reiterated as Outperform and the price target was raised to $52 from $48 (versus a $42.62 close) at Wells Fargo.
Myriad Genetics Inc. (NASDAQ: MYGN) was downgraded to Underweight from Equal Weight and the price target was cut to $30 from $38 (versus a $50.34 close) at Barclays.
Palo Alto Networks Inc. (NYSE: PANW) was reiterated as Outperform and the target price was raised to $254 from $240 (versus a $229.03 close) at Raymond James.
Robert Half International Inc. (NYSE: RHI) was downgraded to Sell from Neutral with a $67 price target (versus a $78.78 close) at Goldman Sachs. The 52-week range is $44.38 to $79.91.
UnitedHealth Group Inc. (NYSE: UNH) was reiterated as Overweight and the price target was raised to $305 from $278 (versus a $268.51 close) at Morgan Stanley.
U.S. Ecology Inc. (NASDAQ: ECOL) was maintained as Sell but the price target was raised to $61 from $56 (versus a $72.60 close) at UBS. The consensus target price was $63.67.
Vail Resorts Inc. (NYSE: MTN) was downgraded to Neutral from Outperform with a $300 price target (versus a $301.42 close) at Macquarie.
Vodafone Group PLC (NASDAQ: VOD) was raised to Outperform from Market Perform at Bernstein.
Xylem Inc. (NYSE: XYL) was started with an Outperform rating and the price target was set at $90 (versus a $75.66 close) at Raymond James.
Tuesday’s top analyst calls were in Apple, AT&T, BBVA, Cisco Systems, Dollar Tree, Facebook, Roku, Seagate Technology, Turkcell, Verizon and many more.